WET AGE RELATED MACULAR DEGENERATION
Clinical trials for WET AGE RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new WET AGE RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for WET AGE RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot gene therapy aims to end monthly eye injections for wet AMD
Disease control Not yet recruitingThis early-stage trial tests EXG202, a gene therapy given as a single injection into the eye for people with wet age-related macular degeneration (AMD). The goal is to see if it is safe and can produce a protein that blocks abnormal blood vessel growth long-term, potentially redu…
Matched conditions: WET AGE RELATED MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: Guangzhou Jiayin Biotech Ltd • Aim: Disease control
Last updated Jun 26, 2026 17:51 UTC
-
Elderly AMD patients to test Easy-to-Use home vision tracker
Knowledge-focused Not yet recruitingThis study aims to see if elderly patients with age-related macular degeneration (AMD) find a new web-based eye-tracking system easy and acceptable to use at home. The system is designed to help patients monitor their vision without frequent clinic visits. Thirty patients aged 55…
Matched conditions: WET AGE RELATED MACULAR DEGENERATION
Sponsor: Tan Tock Seng Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC